{"cluster": 16, "subcluster": 9, "abstract_summ": "In addition, renin\u2013angiotensin aldosterone system inhibitors reduce adverse atherosclerotic cardiovascular disease, heart failure, and chronic kidney disease outcomes, but may increase ACE2 levels.Coronavirus and influenza virus vaccine usage in high CV risk populations could be a potential strategy to prevent both CV disease and coronavirus/influenza virus infections.Severe acute respiratory syndrome coronavirus-2019 (SARS-CoV-2), the causative virus of COVID-19, infects host cells through angiotensin-converting enzyme 2 (ACE2).We review current knowledge of the role of ACE2 in cardiovascular physiology and SARS-CoV-2 virology, as well as clinical data to inform the management of patients with or at risk for COVID-19 who require renin\u2013angiotensin\u2013aldosterone system inhibitor therapy.Angiotensin-converting enzyme 2 (ACE2) has emerged as a key regulator of the renin\u2013angiotensin system in cardiovascular (CV) disease and plays a pivotal role in infections by coronaviruses and influenza viruses.", "title_summ": "The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular diseaseCardiovascular Pharmacology in the Time of COVID-19: A Focus on Angiotensin-Converting Enzyme 2COVID-19-Related StrokeMight renin\u2013angiotensin system blockers play a role in the COVID-19 pandemic?", "title_abstract_phrases": "In addition, renin\u2013angiotensin aldosterone system inhibitors reduce adverse atherosclerotic cardiovascular disease, heart failure, and chronic kidney disease outcomes, but may increase ACE2 levels.We review current knowledge of the role of ACE2 in cardiovascular physiology and SARS-CoV-2 virology, as well as clinical data to inform the management of patients with or at risk for COVID-19 who require renin\u2013angiotensin\u2013aldosterone system inhibitor therapy.The role of angiotensin-converting enzyme 2 in coronaviruses/influenza viruses and cardiovascular diseaseAngiotensin-converting enzyme 2 (ACE2) has emerged as a key regulator of the renin\u2013angiotensin system in cardiovascular (CV) disease and plays a pivotal role in infections by coronaviruses and influenza viruses.Might renin\u2013angiotensin system blockers play a role in the COVID-19 pandemic?Since December 2019, a new coronavirus, named SARS-CoV-2, has spread globally, affecting >200 000 people worldwide with the so-called COVID-19 disease.Coronavirus and influenza virus vaccine usage in high CV risk populations could be a potential strategy to prevent both CV disease and coronavirus/influenza virus infections."}